| Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke W Hacke, M Kaste, E Bluhmki, M Brozman, A Dávalos, D Guidetti, ... New England journal of medicine 359 (13), 1317-1329, 2008 | 8574 | 2008 |
| Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS) W Hacke, M Kaste, C Fieschi, D Toni, E Lesaffre, R Von Kummer, ... Jama 274 (13), 1017-1025, 1995 | 4274 | 1995 |
| Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study N Wahlgren, N Ahmed, A Dávalos, GA Ford, M Grond, W Hacke, ... The Lancet 369 (9558), 275-282, 2007 | 2751 | 2007 |
| Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials KR Lees, E Bluhmki, R Von Kummer, TG Brott, D Toni, JC Grotta, ... The Lancet 375 (9727), 1695-1703, 2010 | 2691 | 2010 |
| Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient … J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ... The Lancet 384 (9958), 1929-1935, 2014 | 2635 | 2014 |
| Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1238-1251, 2008 | 1264 | 2008 |
| Telmisartan to prevent recurrent stroke and cardiovascular events S Yusuf, HC Diener, RL Sacco, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1225-1237, 2008 | 1043 | 2008 |
| European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke G Turc, P Bhogal, U Fischer, P Khatri, K Lobotesis, M Mazighi, ... Journal of neurointerventional surgery 15 (8), e8-e8, 2023 | 944 | 2023 |
| Rivaroxaban for stroke prevention after embolic stroke of undetermined source RG Hart, M Sharma, H Mundl, SE Kasner, SI Bangdiwala, SD Berkowitz, ... New England Journal of Medicine 378 (23), 2191-2201, 2018 | 940 | 2018 |
| European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage T Steiner, RAS Salman, R Beer, H Christensen, C Cordonnier, L Csiba, ... International journal of stroke 9 (7), 840-855, 2014 | 891 | 2014 |
| Thrombolysis with alteplase 3–4· 5 h after acute ischaemic stroke (SITS-ISTR): an observational study N Wahlgren, N Ahmed, A Dávalos, W Hacke, M Millán, K Muir, RO Roine, ... The Lancet 372 (9646), 1303-1309, 2008 | 890 | 2008 |
| Dabigatran for prevention of stroke after embolic stroke of undetermined source HC Diener, RL Sacco, JD Easton, CB Granger, RA Bernstein, S Uchiyama, ... New England Journal of Medicine 380 (20), 1906-1917, 2019 | 633 | 2019 |
| Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry S Sacco, C Marini, D Toni, L Olivieri, A Carolei Stroke 40 (2), 394-399, 2009 | 629 | 2009 |
| Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of … N Wahlgren, N Ahmed, N Eriksson, F Aichner, E Bluhmki, A Dávalos, ... Stroke 39 (12), 3316-3322, 2008 | 590 | 2008 |
| Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours C Fieschi, C Argentino, GL Lenzi, ML Sacchetti, D Toni, L Bozzao Journal of the neurological sciences 91 (3), 311-321, 1989 | 585 | 1989 |
| Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I A Davalos, D Toni, F Iweins, E Lesaffre, S Bastianello, J Castillo Stroke 30 (12), 2631-2636, 1999 | 537 | 1999 |
| Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute … J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ... Lancet 384 (9958), 1929-1935, 2014 | 466 | 2014 |
| Extending thrombolysis to 4· 5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data BCV Campbell, H Ma, PA Ringleb, MW Parsons, L Churilov, M Bendszus, ... The Lancet 394 (10193), 139-147, 2019 | 452 | 2019 |
| Implementation and outcome of thrombolysis with alteplase 3–4· 5 h after an acute stroke: an updated analysis from SITS-ISTR N Ahmed, N Wahlgren, M Grond, M Hennerici, KR Lees, R Mikulik, ... The Lancet Neurology 9 (9), 866-874, 2010 | 444 | 2010 |
| Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation … N Ahmed, N Wahlgren, M Brainin, J Castillo, GA Ford, M Kaste, KR Lees, ... Stroke 40 (7), 2442-2449, 2009 | 439 | 2009 |
